BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 16554730)

  • 1. Renal mucinous tubular and spindle carcinoma lacks the gains of chromosomes 7 and 17 and losses of chromosome Y that are prevalent in papillary renal cell carcinoma.
    Cossu-Rocca P; Eble JN; Delahunt B; Zhang S; Martignoni G; Brunelli M; Cheng L
    Mod Pathol; 2006 Apr; 19(4):488-93. PubMed ID: 16554730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucinous spindle and tubular renal cell carcinoma: analysis of chromosomal aberration pattern of low-grade, high-grade, and overlapping morphologic variant with papillary renal cell carcinoma.
    Peckova K; Martinek P; Sperga M; Montiel DP; Daum O; Rotterova P; Kalusová K; Hora M; Pivovarcikova K; Rychly B; Vranic S; Davidson W; Vodicka J; Dubová M; Michal M; Hes O
    Ann Diagn Pathol; 2015 Aug; 19(4):226-31. PubMed ID: 26009022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metanephric adenoma lacks the gains of chromosomes 7 and 17 and loss of Y that are typical of papillary renal cell carcinoma and papillary adenoma.
    Brunelli M; Eble JN; Zhang S; Martignoni G; Cheng L
    Mod Pathol; 2003 Oct; 16(10):1060-3. PubMed ID: 14559991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Papillary renal cell carcinoma with low-grade spindle cell foci: a mimic of mucinous tubular and spindle cell carcinoma.
    Argani P; Netto GJ; Parwani AV
    Am J Surg Pathol; 2008 Sep; 32(9):1353-9. PubMed ID: 18670354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucinous tubular and spindle cell carcinoma and solid variant papillary renal cell carcinoma: a clinicopathologic comparative analysis of four cases with similar molecular genetics datum.
    Zhang Y; Yong X; Wu Q; Wang X; Zhang Q; Wu S; Yu D
    Diagn Pathol; 2014 Dec; 9():194. PubMed ID: 25476569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gains of chromosomes 7, 17, 12, 16, and 20 and loss of Y occur early in the evolution of papillary renal cell neoplasia: a fluorescent in situ hybridization study.
    Brunelli M; Eble JN; Zhang S; Martignoni G; Cheng L
    Mod Pathol; 2003 Oct; 16(10):1053-9. PubMed ID: 14559990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification.
    Zhou M; Yang XJ; Lopez JI; Shah RB; Hes O; Shen SS; Li R; Yang Y; Lin F; Elson P; Sercia L; Magi-Galluzzi C; Tubbs R
    Am J Surg Pathol; 2009 Dec; 33(12):1840-9. PubMed ID: 19898225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.
    Jones TD; Eble JN; Wang M; MacLennan GT; Delahunt B; Brunelli M; Martignoni G; Lopez-Beltran A; Bonsib SM; Ulbright TM; Zhang S; Nigro K; Cheng L
    Clin Cancer Res; 2005 Oct; 11(20):7226-33. PubMed ID: 16243792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal cell carcinoma with extensive clear cell change sharing characteristics of mucinous tubular and spindle cell carcinoma and papillary renal cell carcinoma.
    Kuroda N; Tamura M; Hes O; Michal M; Kawada C; Shuin T; Lee GH
    Pathol Int; 2009 Sep; 59(9):687-8. PubMed ID: 19712140
    [No Abstract]   [Full Text] [Related]  

  • 10. End-stage kidney disease: gains of chromosomes 7 and 17 and loss of Y chromosome in non-neoplastic tissue.
    Hes O; Síma R; Nemcová J; Hora M; Bulimbasic S; Kazakov DV; Urge T; Reischig T; Dvorák M; Michal M
    Virchows Arch; 2008 Oct; 453(4):313-9. PubMed ID: 18795325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic aberrations in mucinous tubular and spindle cell renal cell carcinomas.
    Brandal P; Lie AK; Bassarova A; Svindland A; Risberg B; Danielsen H; Heim S
    Mod Pathol; 2006 Feb; 19(2):186-94. PubMed ID: 16258504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal cell carcinoma with mixed features of papillary and clear cell cytomorphology: a fluorescent in situ hybridization study.
    Mai KT; Faraji H; Desantis D; Robertson SJ; Belanger EC; Levac J
    Virchows Arch; 2010 Jan; 456(1):77-84. PubMed ID: 20033232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant papillary renal tumors with extensive clear cell change: a molecular analysis by microsatellite analysis and fluorescence in situ hybridization.
    Salama ME; Worsham MJ; DePeralta-Venturina M
    Arch Pathol Lab Med; 2003 Sep; 127(9):1176-81. PubMed ID: 12946227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous chromosome 7 and 17 gain and sex chromosome loss provide evidence that renal metanephric adenoma is related to papillary renal cell carcinoma.
    Brown JA; Anderl KL; Borell TJ; Qian J; Bostwick DG; Jenkins RB
    J Urol; 1997 Aug; 158(2):370-4. PubMed ID: 9224305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncocytic papillary renal cell carcinoma: a clinicopathologic, immunohistochemical, ultrastructural, and interphase cytogenetic study of 12 cases.
    Hes O; Brunelli M; Michal M; Cossu Rocca P; Hora M; Chilosi M; Mina M; Boudova L; Menestrina F; Martignoni G
    Ann Diagn Pathol; 2006 Jun; 10(3):133-9. PubMed ID: 16730306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical analysis of mucinous tubular and spindle cell carcinoma and papillary renal cell carcinoma of the kidney: significant immunophenotypic overlap warrants diagnostic caution.
    Paner GP; Srigley JR; Radhakrishnan A; Cohen C; Skinnider BF; Tickoo SK; Young AN; Amin MB
    Am J Surg Pathol; 2006 Jan; 30(1):13-9. PubMed ID: 16330937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucinous tubular and spindle cell carcinoma of kidney is probably a variant of papillary renal cell carcinoma with spindle cell features.
    Shen SS; Ro JY; Tamboli P; Truong LD; Zhai Q; Jung SJ; Tibbs RG; Ordonez NG; Ayala AG
    Ann Diagn Pathol; 2007 Feb; 11(1):13-21. PubMed ID: 17240302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single nucleotide polymorphism (SNP) chromosomal microarray as a diagnostic tool for mucinous tubular and spindle cell carcinoma: A validation study.
    Nielson KJ; Rowsey R; Dasari S; Sukov WR; Kipp BR; Raghunathan A; Whaley RD; Ebare K; Stanton ML; Reynolds JP; Sharma V; Thompson RH; Boorjian SA; Leibovich BC; Hernandez LH; Jimenez RE; Cheville JC; Gupta S
    Hum Pathol; 2024 Apr; 146():57-65. PubMed ID: 38615998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VSTM2A Overexpression Is a Sensitive and Specific Biomarker for Mucinous Tubular and Spindle Cell Carcinoma (MTSCC) of the Kidney.
    Wang L; Zhang Y; Chen YB; Skala SL; Al-Ahmadie HA; Wang X; Cao X; Veeneman BA; Chen J; Cieślik M; Qiao Y; Su F; Vats P; Siddiqui J; Xiao H; Sadimin ET; Epstein JI; Zhou M; Sangoi AR; Trpkov K; Osunkoya AO; Giannico GA; McKenney JK; Argani P; Tickoo SK; Reuter VE; Chinnaiyan AM; Dhanasekaran SM; Mehra R
    Am J Surg Pathol; 2018 Dec; 42(12):1571-1584. PubMed ID: 30285995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathologic and interphase cytogenetic analysis of papillary (chromophilic) renal cell carcinoma.
    Kattar MM; Grignon DJ; Wallis T; Haas GP; Sakr WA; Pontes JE; Visscher DW
    Mod Pathol; 1997 Nov; 10(11):1143-50. PubMed ID: 9388066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.